EUVIMED · CrossrefZeitschrift
The Pharmacogenomics Journal
ISSN 1470-269X · Springer Science and Business Media LLC
Neueste Artikel
Pharmacogenomics guided clopidogrel utilization in veterans undergoing peripheral arterial intervention with vascular surgery compared to usual care
The impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine
Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies
Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy
A randomized trial to evaluate attitudes regarding pharmacogenomics among pregnant and pediatric populations: design and baseline characteristics
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population
Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in China
Development and validation of an open data model for pharmacogenetics to enable semantic interoperability in clinical practice
Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia
The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke
STRIPE partners in precision medicine series: Patient perspective
STRIPE partners in precision medicine: international perspective
A potential association of SLC2A9 variant rs7442295 with uric acid at baseline and in interaction with iloperidone
Association of folylpolyglutamate synthase polymorphisms with methotrexate response and toxicity in rheumatoid arthritis: a meta-analysis
A pilot study of pharmacogenomic testing as a tool to enhance depression care in Veterans
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study
Combined Role of CYP3A4 and CYP3A5 genetic variants in tacrolimus dose-adjusted trough levels: a clinical retrospective study in kidney transplant patients
Use of medications with pharmacogenomic guidelines and adverse outcomes in hospitalised older patients: a retrospective cross-sectional study
A functional ancestry-linked regulatory haplotype influences CYP2D6 expression
Antidepressant drug switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: a drug utilization study using claims data
Utilisation of drugs with pharmacogenetic recommendations in children in Switzerland
Implementing CYP2C19-guided clopidogrel therapy: a scoping review of pharmacogenomic testing services
Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach
A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study)
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients
Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn’s disease patients
EUVIMED